Page last updated: 2024-09-03

omega-n-methylarginine and incretins

omega-n-methylarginine has been researched along with incretins in 1 studies

Compound Research Comparison

Studies
(omega-n-methylarginine)
Trials
(omega-n-methylarginine)
Recent Studies (post-2010)
(omega-n-methylarginine)
Studies
(incretins)
Trials
(incretins)
Recent Studies (post-2010) (incretins)
4,4113443362,3732491,914

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andrews, CN; Bharucha, AE; Camilleri, M; Charkoudian, N; Low, PA; Sletten, D; Zinsmeister, AR1

Trials

1 trial(s) available for omega-n-methylarginine and incretins

ArticleYear
Effects of glucagon-like peptide-1, yohimbine, and nitrergic modulation on sympathetic and parasympathetic activity in humans.
    American journal of physiology. Regulatory, integrative and comparative physiology, 2008, Volume: 295, Issue:3

    Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Blood Glucose; Blood Pressure; Catecholamines; Enzyme Inhibitors; Female; Glucagon-Like Peptide 1; Heart Rate; Humans; Incretins; Male; Middle Aged; Muscle, Skeletal; Nitric Oxide; omega-N-Methylarginine; Parasympathetic Nervous System; Sympathetic Nervous System; Vasoconstriction; Yohimbine

2008